Form 4: Zimmer Biomet Executive Wilfred van Zuilen Reports Stock Transactions

Wilfred van Zuilen, Group President EMEA at Zimmer Biomet, reports the vesting of restricted stock units and subsequent stock transactions on March 6, 2025.

Summary

• On March 6, 2025, Wilfred van Zuilen, Group President EMEA of Zimmer Biomet Holdings, Inc., reported transactions involving the company's common stock.
• 2,162 restricted stock units (RSUs) vested, each representing a contingent right to receive one share of Zimmer Biomet common stock.
• Van Zuilen acquired 2,162 shares of common stock upon the vesting of these RSUs.
• 569 shares were withheld by the company to satisfy tax withholding obligations at a price of $104.86 per share.
• Following these transactions, Van Zuilen directly owns 19,534 shares of common stock and 2,161 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with neutral sentiment.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It is a standard practice for executives at publicly traded companies like Zimmer Biomet.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.

Key Dates